Home
Conditions
Malignant Peripheral Nerve Sheath Tumor

Clinical trial condition

Malignant Peripheral Nerve Sheath Tumor

Explore clinical trials studying Malignant Peripheral Nerve Sheath Tumor. Study availability and eligibility vary by location and protocol.

10 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Malignant Peripheral Nerve Sheath Tumor trial results

Recruiting

Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

NCT04222413

Conditions: Advanced Breast Cancer, Advanced Solid Tumors, Colonic Diseases, +32 more
Locations: University of Kansas Fairway, Kansas, United States

National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Neurofibromatosis Type 1 Tumor Early Detection Study

NCT06515860

Conditions: Atypical Neurofibroma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fibrosarcoma, +28 more
Locations: Boston Children's Hospital Boston, Massachusetts, United States

View Trial Details

Not Yet Recruiting

Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma

NCT06526897

Conditions: AJCC Grade 2 Sarcoma, AJCC Grade 3 Sarcoma, Adult Pleomorphic Rhabdomyosarcoma, +46 more
Locations: Not specified

View Trial Details

Completed

Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery

NCT02180867

Conditions: Alveolar Soft Part Sarcoma, Angiomatoid Fibrous Histiocytoma, Atypical Fibroxanthoma, +65 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

The Kirklin Clinic at Acton Road Birmingham, Alabama, United States

Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States

View all 381 locations

View Trial Details

Completed

Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma

NCT02584309

Conditions: Angiosarcoma, Dermatofibrosarcoma, Epithelioid Sarcoma, +31 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors

NCT00931931

Conditions: Clival Chordoma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Ewing Sarcoma, +46 more
Locations: Nationwide Children's Hospital Columbus, Ohio, United States

View Trial Details

Completed

Sorafenib and Dacarbazine in Soft Tissue Sarcoma

NCT00837148

Conditions: Fibrosarcoma, Leiomyosarcoma, Malignant Peripheral Nerve Sheath Tumor, +18 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Active, Not Recruiting

Natural History Study of Patients With Neurofibromatosis Type I

NCT00924196

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +38 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Active, Not Recruiting

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

NCT02834013

Conditions: Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States

Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States

Anchorage Radiation Therapy Center Anchorage, Alaska, United States

View all 1007 locations

View Trial Details

Active, Not Recruiting

Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma

NCT04420975

Conditions: Dermatofibrosarcoma, Fibrosarcoma, Histiocytoma, +48 more
Locations: UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Malignant Peripheral Nerve Sheath Tumor

Malignant Peripheral Nerve Sheath Tumor trial results

Related conditions